Trials

ABILITY DIABETES GLOBAL is a prospective, multi-center, multinational, randomized, open label (follow-ups blinded), 2-arm parallel groups study. The objective is to compare in diabetic patients eligible for percutaneous coronary intervention (PCI) with minimal exclusion criteria, the efficacy and...

All Women study is a unique newly launching randomized controlled trial targeting female population older than 75 years old with symptomatic aortic stenosis. The objective is to demonstrate lower mean gradient by Echo 30 days after TAVI procedure with Allegra (Biosensors), versus patients treated by...

ART-ASPI CATHETER-01 study is an observational, prospective, post-market, single arm, open label, multicentre study. Within this trial, 60 patients are planned to be enrolled. During the trial, clinical data will be collected and evaluated from the use of the aspiration catheter during percutaneous...

ART-PCTA-01 study is an observational, prospective, post-market, single arm, open label, multicentre study. Within this trial, 60 patients are planned to be enrolled. During the trial, clinical data of the Arthesys PTCA catheters family will be collected during angioplasty intervention of coronary...

ART-PCTA-02 study is an observational, prospective, post-market, single arm, open label, multicentre study. Within this trial, 60 patients are planned to be enrolled. During the trial, clinical data of the Arthesys PTCA non-compliant catheters family will be collected during angioplasty intervention...

BIOME wishes to perform a specific study to validate and refine their CT FFR algorithm. The data comprises coronary computed tomography angiography (CCTA) with at least one vessel with invasively measure fractional flow reserve (FFR).

The ContraBand™ device is intended for treatment of heart failure patients who remain symptomatic despite the use of optimally tolerated guideline directed medical therapy.

This is a prospective, multicenter, exploratory single arm and controlled clinical investigation compared to recent historical results. This pre-CE marked trial is conducted in two countries (France and the UK) with 5 Investigation sites participate to the trial. The recruitment was finalized in...

An international, multicenter, prospective, randomized clinical investigation to evaluate the safety and effectiveness of the Conformal CLAAS System for left atrial appendage occlusion, in comparison to the commercially available WATCHMAN® and Amulet™ left atrial appendage closure devices in...

CYCLOPES is a prospective, multicenter, open-label, single arm trial assessing the feasibility and efficacy of an intracoronary ultrasound guided algorithm for calcium modification in patients undergoing percutaneous coronary intervention (PCI) for chronic calcific coronary artery disease. The study...